Our Products
Loans
Cards
Insurance
Investment
Stock Market
Electronics Mall
CIBIL Score
Knowledge Centre
Academy 
Calculators
Our Services
Cibil Report
Get cibil report
My Account
Log In
Log into your account
Offers
Check out pre-approved offers now!
Languages
Chosen Language: English
Do Not Call
Do not call
En
Unick Fix-A-Form And Printers Ltd. Share Price
N/A
1D
1M
3M
6M
1Y
5Y
Day's Range
Day's Range
Low
₹
High
₹
Price Summary
| Previous Close | ₹49.03 |
|---|---|
| Day's Range | ₹49.03 - ₹49.03 |
| Open | ₹49.03 |
| 52 Week Range | ₹39.00 - ₹75.45 |
| Volume | 1 |
| Market Cap | ₹0.00 |
Stocks Summary
| Trade Value ( ₹ in Lacs) | 0.00 |
|---|---|
| Market Cap (₹ in Mn) | 0.00 |
| Dividend Yield(%) | 0.00 |
| Price/Earning (TTM) | 32.13 |
| TTM EPS (₹) | 1.53 |
| P/E Ratio | 15.34 |
| Book Value(₹) | 0.74 |
| PAT Margin (%) | 4.66 |
| Face Value (₹) | 10.00 |
| ROCE(%) | 10.22 |
Financials
| Particulars | QTR FY (₹ in Millions) | Annual FY (₹ in Millions) |
|---|---|---|
| Net sales | 171.5 | 559.79 |
| Expenses | N/A | N/A |
| PBT | 15.05 | 35.15 |
| Operating profit | 0.0 | 0.0 |
| Net profit | 11.22 | 26.1 |
About Unick Fix-A-Form And Printers Ltd.
| Founded | 1993 |
|---|
Peer Comparision
| Stocks Name | Market Cap (Cr)(₹) | Market Price (₹) | 52 Week Low-High (₹) |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | 4,61,847.99 | 1,924.90 | 1,548.00 - 1,548.00 |
| Divi's Laboratories Ltd. | 2,25,648.29 | 8,500.00 | 5,636.50 - 5,636.50 |
| Torrent Pharmaceuticals Ltd. | 1,84,109.45 | 4,840.30 | 3,480.60 - 3,480.60 |
| Apollo Hospitals Enterprise Ltd. | 1,28,327.81 | 8,925.00 | 6,696.50 - 6,696.50 |
| Cipla Ltd. | 1,17,138.71 | 1,450.00 | 1,165.70 - 1,165.70 |
| Zydus Lifesciences Ltd. | 1,13,715.44 | 1,140.00 | 835.50 - 835.50 |
| Lenskart Solutions Ltd. | 1,06,480.32 | 611.40 | 0.00 - 0.00 |
| Lupin Ltd. | 1,02,192.00 | 2,235.00 | 1,875.00 - 1,875.00 |
| Dr. Reddy's Laboratories Ltd. | 1,00,328.03 | 1,202.00 | 1,101.00 - 1,101.00 |
| Mankind Pharma Ltd. | 99,945.03 | 2,420.00 | 1,909.70 - 1,909.70 |
No Records Found
Latest News
Jun
5
2026
Posted on Jun 5th 2026
Unick Fix-A-Form and Printers informs about demise of managing director
Unick Fix-A-Form and Printers has informed about the sad demise of Bhupen Navnit Versa, Managing Director (DIN: 00150585) of the Company on Thursday, 04th Lune, 2026, which was intimated by the family members of Bhupen Navnit Vasa, yesterday i.e. on 04th Lune, 2025. Long association and his vision & leadership during his tenure of Bhupen Navnit Vasa, on the Board of the Company was immensely benefitted the Company. His sudden and unexpected passing away will be an irreparable loss to the Company. All the directors and employees of the Company convey deep sympathy, sorrow and condolences to his family.
The above information is a part of company’s filings submitted to BSE.
Read More
May
30
2026
Posted on May 30th 2026
Unick Fix-a-form & Printers informs about annual secretarial compliance report
Pursuant to the Regulation 24A of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Unick Fix-a-form & Printers has informed that it enclosed the Annual Secretarial Compliance Report of the Company issued by Practicing Company Secretary for the year ended 31st March, 2026.
The above information is a part of company’s filings submitted to BSE.
Read More
Aug
15
2026
Posted on Aug 15th 2026
Natco Pharma - Quaterly Results
The Sales for the quarter ended June 2026 of Rs. 5966.00 million declined by -49.98% from Rs. 11927.00 millions.The company reported a drastic decline of -83.93% in the quarter ended June 2026 to Rs. 746.00 millions from Rs. 4641.00 millions .The Operating Profit of the company witnessed a decrease to 1543.00 millions from 5993.00 millions.
| (Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202606 | 202506 | % Var | 202606 | 202506 | % Var | 202603 | 202503 | % Var | |
| Sales | 5966.00 | 11927.00 | -49.98 | 5966.00 | 11927.00 | -49.98 | 35946.00 | 40945.00 | -12.21 |
| Other Income | 483.00 | 596.00 | -18.96 | 483.00 | 596.00 | -18.96 | 2811.00 | 3213.00 | -12.51 |
| PBIDT | 1543.00 | 5993.00 | -74.25 | 1543.00 | 5993.00 | -74.25 | 15860.00 | 24656.00 | -35.67 |
| Interest | 96.00 | 26.00 | 269.23 | 96.00 | 26.00 | 269.23 | 323.00 | 196.00 | 64.80 |
| PBDT | 1447.00 | 5967.00 | -75.75 | 1447.00 | 5967.00 | -75.75 | 15537.00 | 24460.00 | -36.48 |
| Depreciation | 427.00 | 538.00 | -20.63 | 427.00 | 538.00 | -20.63 | 1896.00 | 2200.00 | -13.82 |
| PBT | 1020.00 | 5429.00 | -81.21 | 1020.00 | 5429.00 | -81.21 | 13641.00 | 22260.00 | -38.72 |
| TAX | 274.00 | 788.00 | -65.23 | 274.00 | 788.00 | -65.23 | 826.00 | 3756.00 | -78.01 |
| Deferred Tax | 164.00 | -272.00 | -160.29 | 164.00 | -272.00 | -160.29 | -1858.00 | -319.00 | 482.45 |
| PAT | 746.00 | 4641.00 | -83.93 | 746.00 | 4641.00 | -83.93 | 12815.00 | 18504.00 | -30.74 |
| Equity | 358.00 | 358.00 | 0.00 | 358.00 | 358.00 | 0.00 | 358.00 | 358.00 | 0.00 |
| PBIDTM(%) | 25.86 | 50.25 | -48.53 | 25.86 | 50.25 | -48.53 | 44.12 | 60.22 | -26.73 |
Read More
Aug
15
2026
Posted on Aug 15th 2026
Alkem Laboratories - Quaterly Results
The June 2026 quarter revenue stood at Rs. 26677.30 millions, up 12.46% as compared to Rs. 23721.70 millions during the corresponding quarter last year.Net profit declined -8.40% to Rs. 5699.80 millions from Rs. 6222.60 millions.The company reported a good operating profit of 8731.60 millions compared to 7370.60 millions of corresponding previous quarter.
| (Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202606 | 202506 | % Var | 202606 | 202506 | % Var | 202603 | 202503 | % Var | |
| Sales | 26677.30 | 23721.70 | 12.46 | 26677.30 | 23721.70 | 12.46 | 96639.10 | 88134.40 | 9.65 |
| Other Income | 1366.20 | 1165.80 | 17.19 | 1366.20 | 1165.80 | 17.19 | 5551.70 | 5070.60 | 9.49 |
| PBIDT | 8731.60 | 7370.60 | 18.47 | 8731.60 | 7370.60 | 18.47 | 29795.60 | 26632.60 | 11.88 |
| Interest | 175.20 | 127.90 | 36.98 | 175.20 | 127.90 | 36.98 | 572.90 | 761.10 | -24.73 |
| PBDT | 8556.40 | 7385.60 | 15.85 | 8556.40 | 7385.60 | 15.85 | 27791.80 | 25871.50 | 7.42 |
| Depreciation | 572.20 | 588.90 | -2.84 | 572.20 | 588.90 | -2.84 | 2565.60 | 2836.10 | -9.54 |
| PBT | 7984.20 | 6796.70 | 17.47 | 7984.20 | 6796.70 | 17.47 | 25226.20 | 23035.40 | 9.51 |
| TAX | 2284.40 | 574.10 | 297.91 | 2284.40 | 574.10 | 297.91 | 3375.00 | 2138.20 | 57.84 |
| Deferred Tax | 207.00 | -519.30 | -139.86 | 207.00 | -519.30 | -139.86 | -945.00 | -1363.10 | -30.67 |
| PAT | 5699.80 | 6222.60 | -8.40 | 5699.80 | 6222.60 | -8.40 | 21851.20 | 20897.20 | 4.57 |
| Equity | 239.10 | 239.10 | 0.00 | 239.10 | 239.10 | 0.00 | 239.10 | 239.10 | 0.00 |
| PBIDTM(%) | 32.73 | 31.07 | 5.34 | 32.73 | 31.07 | 5.34 | 30.83 | 30.22 | 2.03 |
Read More
Aug
14
2026
Posted on Aug 14th 2026
Lincoln Pharmaceuticals informs about press release
Lincoln Pharmaceuticals has informed that it enclosed copies of newspaper intimation with respect to the unaudited (standalone & Consolidated) Financial Results of the Company for the Quarter Ended 30 June, 2026.
The above information is a part of company’s filings submitted to BSE.
Read More
No Records Found
Sign in to Unlock Offers!
We don't SPAM
Frequently Asked Questions
The current share price of Unick Fix-A-Form And Printers Ltd. is ₹49.03 as of 2026-08-14.
The market capitalisation of Unick Fix-A-Form And Printers Ltd. is ₹26.89 as of 2026-08-14.
The 1-year return of Unick Fix-A-Form And Printers Ltd. is -25.36% as of 2026-08-14.
The P/E ratio of Unick Fix-A-Form And Printers Ltd. is 15.34 as of 2026-08-15.
The 52-week high and low of Unick Fix-A-Form And Printers Ltd. are ₹75.45 and ₹39.00, respectively, as of 2026-08-14.
View More
Disclaimer
All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.
The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.
Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform.
Home
Shopping
Loan Offers
My Accounts
Explore
